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We conclude that FK506 is highly effective in living-related 
partial liver transplantation, not only in terms of its immuno-
suppressive potential but also because it produces fewer adverse 
reactions. 
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ADULT RESPIRATORY DISTRESS SYNDROME SECONDARY TO 
END-STAGE LIVER DISEASE-SUCCESSFUL OUTCOME 
FOLLOWING LIVER TRANSPLANTATION! 
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The adult respiratory distress syndrome (ARDS) com-
plicating liver failure carries a 100% mortality. Two 
cases of ARDS that resolved following liver transplan-
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tation have been reported, one associated with acute 
allograft rejection, and the second due to sepsis. There 
is, however, a great reluctance to transplant these very-
high-risk patients. We report the first series of patients 
with ARDS secondary to liver failure who successfully 
underwent OLTX. No patient had sepsis or pneumonia. 
Posttransplant mechanical ventilation was required for 
a median of 14 days (range 6-37 days). All patients in 
this series are alive and well, with a follow-up of 6-15 
months. This demonstrates that ARDS associated with 
liver failure, an otherwise uniformly lethal complica-
tion, can respond dramatically to OLTX. 
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The adult respiratory distress syndrome (ARDS)* is fre-
quently seen complicating liver failure. Once established, it is 
irreversible, despite the most aggressive medical management 
(1). There have been two cases reported in the literature in 
which resolution of this syndrome followed orthotopic liver 
transplantation. The first case was that of a patient who 
underwent OLTX at our institution, and who developed ARDS 
in association with severe rejection of the allograft. This re-
solved completely after retransplantation (2). The second pa-
tient had sepsis and ARDS complicating liver failure. After the 
sepsis was brought under control, the patient underwent a 
successful OLTX and eventually recovered (3). 
Most clinicians, however, are usually reluctant to consider 
OLTX in the presence of ARDS. This is because these patients 
are always desperately ill, and an underlying septic focus can 
be difficult to exclude. Recently, we managed several patients 
who developed an ARDS picture in association with end-stage 
liver disease (ESLD), and who successfully underwent OLTX. 
The excellent results in this small series suggest that, in care-
fully selected patients, OLTX will lead to the resolution of an 
otherwise lethal combination of failing organs. 
MATERIALS AND METHODS 
During a period of nine months extending from June of 1990 to 
March of 1991, five patients with ESLD and associated ARDS under· 
went primary OLTX at Presbyterian University Hospital. Pittsburgh. 
During the perioperative period they were all under the care of one of 
the authors (H.R.D.). Follow-up ranged from 4 to 15 months. The data 
were gathered retrospectively through a review of the patients' charts. 
All patients were admitted preoperatively to the Liver Transplant 
Intensive Care Unit, and required mechanical ventilation. Four patients 
had a pulmonary artery catheter inserted upon arrival at the ICU to 
monitor filling pressures and cardiopulmonary profiles. The fifth pa-
tient, a 13-year-old boy, was managed with a central venous line. 
Besides routine monitoring of blood chemistries (4), a thorough search 
for sepsis was conducted. This included an abdominal CT scan, as well 
as sputum, urine, and blood cultures. If indicated, a paracentesis was 
performed and the ascitic fluid sent for routine cultures and cell count. 
Four of the patients underwent bronchoscopy, and either a quantitative 
bronchoalveolar lavage or a protected brush specimen (PBS) of a 
radiographically diseased lobar segment. Since all patients had diffuse 
infiltrates, the choice of a specific segment was left to the individual 
operator. The fifth patient was a Jehovah's Witness who had a coagu-
lopathy that could not be corrected prior to transplant due to religious 
objections to the administration of blood products. Also, the size of his 
endotracheal tube (6.0) would not allow fiberoptic bronchoscopy. Under 
these circumstances we thought that airway manipulation would pose 
an unjustifiable risk of hemorrhage-and, as such, only sputum cultures 
were obtained. The anesthetic management was uniform. Anesthesia 
was maintained with the use of an oxygen air mixture, isoflurane, 
fentanyl, lorazepam, and vecuronium. A Siemens 900D ventilator was 
used intraoperatively, which allowed for continuous assessment of peak 
airway pressures, fraction of inspired oxygen, expired tidal volume, and 
level of positive end-expiratory pressure. Venovenous bypass was used 
in all cases. 
Definitions. Spontaneous bacterial peritonitis was defined as a posi-
tive ascitic fluid culture and/or an absolute neutrophil count >250/ml 
(5). 
Ventilator-associated pneumonia was defined as persistent pulmo-
nary infiltrates that did not clear after vigorous pulmonary toilet, 
together with purulent sputum and a positive quantitative culture 
obtained by either BAL or PBS. A quantitative BAL was positive if it 
* Abbreviations: ARDS, adult respiratory distress syndrome; ESLD, 
End-stage liver disease; LIS, lung injury score; PBS, protected brush 
specimen. 
grew >10' colonies/mI, whereas the cut-off point was> 103 colonies/ml 
for a quantitative PBS. Lower colony counts were considered to reflect 
colonization (6, 7), whether or not the patient was receiving systemic 
antibiotics at the time. 
ARDS was defined as the combination of bilateral diffuse infiltrates 
on chest radiography, decreased pulmonary compliance, and hypozemia 
requiring supplemental ozygen. In addition, the pulmonary artery 
occlusion pressure had to be <18 mmHg. A lung injury score (LIS) was 
determined according to the method of Murray et al. (8), as shown in 
Table 1. 
Statistical analysis. The data are presented as the median and the 
range. Statistical comparisons were made using the Wilcoxon rank sum 
test. Significance was defined at a P<0.05 level. 
RESULTS 
The general patient characteristics are presented in Table 2. 
All patients were male, and the median age was 45 years (range 
13-55). Three patients had alcoholic cirrhosis, one had post-
necrotic cirrhosis due to hepatitis B, and one had fulminant 
hepatic failure of unknown etiology. Advanced liver failure was 
noted in all, with a median total bilirubin of 18.7 mg/dl (range 
8.7-26.0), and a median prothrombin time of 17.4 sec (range 
16.7-18.6). Four patients were receiving frequent infusions of 
fresh frozen plasma to permit invasive instrumentation. Patient 
D.W. was in grade IV coma, while the remaining patients were 
intentionally sedated to facilitate their management. 
Table 3 shows the respiratory system data. An LIS was 
calculated for each patient by assessing four parameters: mag-
nitude of the infiltrates seen on chest roentgenogram, respira-
tory system compliance, hypoxemia index, and the level of 
PEEP (8). This index has a maximum value of 4. The median 
TABLE 1. Components and individual values of the lung injury 
score°,b 
1. Chest roentgenogram score: 
No alveolar consolidation: 0 
Alveolar consolidation in 1 quadrant: 1 
Alveolar consolidation in 2 quadrants: 2 
Alveolar consolidation in 3 quadrants: 3 
Alveolar consolidation in 4 quadrants: 4 
2. Hypoxemia score (Pa02/FI02): 
>300: 0 
225-299: 1 
175-224:2 
100-174: 3 
<100: 4 
3. PEEP score (when ventilated): 
<5 em H20: 0 
6-8 em H20: 1 
9-11 cm H20: 2 
12-14 em H20: 3 
>15 em H20: 4 
4. Respiratory system compliance score: 
>80 ml/cm H20: 0 
60-79 ml/cm H20: 1 
40-59 ml/cm H20: 2 
20-39 ml/cm H20: 3 
<19 ml/cm H20: 4 
o The final score is the aggregate sum divided by the number of 
components used: 0 = no lung injury; 0.1-2.5 = mild-to-moderate lung 
injury; >2.5 = severe lung injury (ARDS); Pa02/FI02 = arterial oJ:ygen 
tension to inspired oxygen concentration ratio; PEEP = positive end-
expiratory pressure. 
b (SOURCE: Murray JF, et al. Am Rev Respir Dis 1988; 138:720 [by 
permission from the publisher]). 
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TABLE 2. Clinical and microbiological featureaA 
Patient Age/sex Ox Bili Temp WBC/%banda Platelets PT Culture. (mg/d1) ('C) (per ml) (sec) 
E.C. 45/M PNCE 15.1 37.5 11,300/15% 93,000 16.7 <103/ml E faecab8 
and C albicans 
(BAL) 
J.G. 41/M CAHB 18.9 38.4 11,500/15% 39,000 18.6 <loa /m! coagulase 
( -) Staphylococ-
cus (BAL) 
D.W. 13/M FHF 26.0 37.9 N/A N/A N/A' Light coagulase 
(-) Staphylococ-
cus (sputum) 
D.R. 47/M PNCE 8.7 37.2 7,800/18% 46,000 16.8 Sterile (PBS) 
E.F. 55/M PNCE 18.7 38.1 7,400/12% 48.000 18 Sterile (PBS) 
" Laboratory values obtained within 24 hr prior to transplant. All cultures performed within one week prior to transplant. 
b Abbreviations: Ox = diagnosis; Bili = bilirubin; Temp = temperature; PT = prothrombin time; PBS = protected brush specimen; BAL = 
bronchoalveolar lavage; PNCE = postnecrotic cirrhosis due to ethanol; FHF = fulminant hepatic failure; CAHB = chronic active hepatitis B. 
, PT 14 days prior to transplant = 22.3 s. 
TABLE 3. Rp-spiratory system parameters" 
Patient CXR· score EDC PaO./FIO. PEEP LIS 
E.C. 4 16 226 5 2.3 
J.G. 4 20 103 15 3.5 
D.W. 4 14 260 10 2.8 
D.R. 4 20 255 10 2.3 
E.F. 4 21 210 5 2.3 
" Within 24 hr prior to transplantation. 
b Abbreviations: CXR = chest roentgenogram; EDC = effective dy-
namic compliance (ml/cmH20) Pa02/FI02 = arterial oxygen ten-
sion:inspired oxygen concentration ratio. LIS = lung injury score; 
PEEP = positive end-expiratory pressure (cmH20). 
LIS within 24 hr prior to undergoing OL TX was 2.3 (range 
2.3-3.5). No patient was turned down for transplantation based 
on the severity of the LIS. Mechanical ventilation was required 
after transplantation for a median of 14 days (range 6-37). As 
can be seen in Figure 1. on the day mechanical ventilation was 
stopped the median LIS had decreased to 1.0 (range 0.5-1.5 
[P<0.005]). 
An important concern prior to transplantation was to estab-
lish whether any of the patients was infected. As can be seen 
in Tables 2 and 4, all patients for whom data are available had 
a clinical picture compatible with sepsis (patient D.W_ was a 
Jehovah's Witness in whom laboratory work was strictly lim-
ited). Two patients were febrile. All had thrombocytopenia and 
a left shift in the differential leukocyte count. As is character-
istic of liver failure. these patients had hyperdynamic circula-
tion, with a cardiac index that ranged between 6.0 and 9.7 L/ 
min/m2. and systemic vascular resistance index from 492 to 
636 dyne/sec/cm5/m2 (Table 4). Pulmonary artery occlusion 
pressures were maintained between 14 and 15 mmHg. Blood. 
urine, and ascitic fluid cultures were consistently negative. The 
absolute neutrophilic count in the ascitic fluid was below 250 
in every case examined. Sputum cultures in patient D_W. had 
a light growth of coagulase-negative Staphylococcus. Due to the 
particular organism. the light growth, and the chest roentgen-
ogram pattern. it was thought that this represented colonization 
rather than infection. Table 2 shows the respiratory cultures. 
Two patients had protected brush specimens that failed to grow 
any organisms, and two other patients had a quantitative BAL 
that grew fewer than 103 organisms. They were all on systemic 
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FIGURE 1. Lung injury scores on the day of OLTX and on the day 
mechanical ventilation was stopped. 
antibiotics at the time the cultures were obtained. All patients 
underwent a successful liver transplant_ The effective dynamic 
lung compliance and alveoloarterial oxygen difference (AaD02) 
remained the same throughout the operation, without improve-
ment upon graft reperfusion. 
The time to resolution of the pulmonary infiltrates was 
variable. but improvement was evident by the end of the first 
week posttransplant. In one case residual changes were still 
present at the end of one month. Mechanical ventilation was 
------ ----------
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~~~ TABLE 4. Hemodynamic parameters" 
Patient PaOO CI SVRI 
E.C. 14 7.8 492 
J.G. 14 6.0 636 
D.W. N/A' N/A N/A 
D.R. 15 9.7 533 
E.F. 16 7.7 541 
• Within 24 hr prior to transplantation. 
b Abbreviations: PaO = pulmonary artery occlusion pressure 
(mmHg); CI = cardiac index (L/min/m2); SVRI = systemic vascular 
resistance index (dyne.s/cms .m2). 
CVP = 10. 
required for a median of 14 days posttransplant (range 6-37). 
All patients are doing well, and are back in their communities 
6-15 months after transplantation. 
DISCUSSION 
The prognosis for patients suffering from ESLD who require 
mechanical ventilation for any reason is poor, with a mortality 
approaching 90% (9, 10). ARDS is a frequent complication of 
advanced liver failure, whether chronic or acute. Matuschak et 
a1. retrospectively studied 29 patients with advanced nonalco-
holic ESLD who were in an ICU for at least 24 hr (1). Of these, 
23 eventually developed ARDS (79%), compared with only 3 of 
44 control patients (6.8%). Sepsis was the most common risk 
factor for the development of ARDS in both groups, with 18 of 
23 (78%) ESLD patients being clinically septic before ARDS 
developed. More important, the course of the respiratory failure 
was irreversible regardless of the presumed etiology. Nonre-
solving ARDS was a direct or indirect cause of death in 12 of 
23 (52%) patients, and a contributing cause of death in the 
remaining patients (J). The combination of liver failure and 
ARDS, therefore, carries a mortality of 100%, as compared with 
60-70% for ARDS in a variety of other settings (11-14). 
Patients with advanced liver disease appear to be at high risk 
for irreversible ARDS, probably because of the central role the 
liver plays in host defenses (15). Although the pathogenesis of 
ARDS is still not completely understood, certain key elements 
have emerged. The role of circulating endotoxin in initiating 
an inflammatory cascade that will eventually lead to panen-
dothelial injury has been suggested (16). This injury is probably 
initiated by activated neutrophils, but it can also take place 
through neutrophil-independent mechanisms (16, 17). The 
liver, specifically the Kupffer cell mass, is critical in the detox-
ification of gut-derived bacteria and their products. Liver fail-
ure or Kupffer cell blockade can lead to a "spillover" of toxins 
into the systemic circulation (I8, 19). Severe hepatic dysfunc-
tion can not only increase the likelihood of ARDS, but may 
also modulate its resolution (1). There have been several studies 
performed by our group looking at the relationship between 
perioperative endotoxemia and outcome following OL TX. Yo-
koyama et a1. have recently emphasized the deleterious conse-
quences caused by the wave of endotoxemia that follows the 
anhepatic phase, which can lead to profound graft dysfunction 
and decreased patient survival (20), and in a separate study by 
Miyata et aI., addressing specifically the issue of pulmonary 
complications, a significant correlation was found between high 
levels of endotoxin and the need for prolonged postoperative 
ventilatory support (21). We did not perform endotoxin deter-
minations in any of our patients. 
In keeping with the preceding discussion, OL TX has been 
reported to lead to resolution of established ARDS associated 
with preexisting liver failure (2,3). In the first case, respiratory 
failure was caused by severe liver allograft rejection (2). Hepatic 
retransplantation started approximately 9 hr after the diagnosis 
of ARDS was made, and the patient was extubated 48 hr after 
the completion of the operation. In another case (3), a patient 
with cirrhosis and ulcerative colitis developed ARDS following 
Bacteroides sepsis. Although the sepsis was brought under 
control, she continued to have nonresolving ARDS. At this 
point she underwent a successful OL TX and the ARDS even-
tually resolved. In contrast to these two cases, none of our 
patients had any known predisposing factor such as sepsis, 
aspiration, multiple transfusions, pancreatitis, or drugs. There-
fore, they appear to have developed ARDS solely on the basis 
of advanced liver failure. 
Besides the patient we already mentioned (2), we have spo-
radically in the past performed a primary OL TX in patients 
having both liver failure and a picture consistent with ARDS. 
However, these patients did not undergo the complete and 
systematic evaluation to rule out infection that we performed 
in the present series, and are, therefore, not included in this 
report. The decision to proceed with transplantation in these 
cases has always been taken reluctantly. This is because the 
sepsis syndrome that accompanies advanced liver failure can 
be very difficult to differentiate from that due to a serious 
infection. which is a formal contraindication to transplantation. 
As can be seen from Tables 3 and 4 our patients demonstrated 
the hyperdynamic state characteristic of either condition. They 
were also thrombocytopenic, coagulopathic, and had a signifi-
cant left shift. In trying to determine whether the patients had 
a concomitant infection, we performed repeated cultures of 
blood, urine, and ascitic fluid. Given the uncertainty of the 
clinical situation, once the appropriate samples had been col-
lected the patients were placed empirically on broad-spectrum 
antibiotics. These were continued until the final cultures were 
back, and found to be negative. In addition, abdominal CT 
scans were performed to exclude the possibility of an abscess, 
and liver ultrasounds obtained to evaluate the biliary tree and 
the patency of the hepatic vessels. None of the patients had 
bacteremia, urinary tract infections, or spontaneous bacterial 
peritonitis. The imaging studies were unrevealing, except for 
the expected presence of a small liver and ascites. At this point 
the most difficult challenge was to rule out an underlying 
pneumonia. Since positive sputum cultures are common in 
intubated patients, and the chest roentgenogram pattern is 
unreliable when trying to distinguish infectious from noninfec-
tious infiltrates, we performed fiberoptic bronchoscopy and 
quantitative BAL or PBS in four of the five patients. We used 
a colony count of >105/ml for quantitative BAL, and >103/ml 
for PBS to differentiate between colonization and infection (6, 
7). As can be seen in Table 2 none of our patients met these 
criteria for pneumonia. Patient D.W. did not have a bronchos-
copy due to his uncorrectable coagulopathy and relatively small 
endotracheal tube. He had a light growth of coagulase-negative 
Staphylococcus from sputum, which was thought to be a con-
taminant. We recognize that the respiratory cultures were 
obtained while the patients were receiving empiric systemic 
antibiotics, which may have diminished their accuracy (6). 
However, since these patients received only routine postoper-
ative antibiotic prophylaxis (intravenous ampicillin and cefo-
taxime for 72 hr), and the pulmonary picture resolved in all 
despite being immunosuppressed, we are confident that our 
initial interpretation of the culture results was correct. 
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Regarding the magnitude of the lung injury, the lung injury 
scores (8) ranged from 2.3 to 3.5 on the day of transplantation, 
and improved significantly after the operation (Fig. 1). The 
most salient clinical features were those of diffuse bilateral 
pulmonary infiltrates in the presence of relatively normal filling 
pressures-and, accompanied by a significantly reduced com-
pliance, all were consistent with ARDS. However, in contrast 
to ARDS in other groups of patients, oxygenation was easily 
maintained on mechanical ventilation, except for patient J.G. 
(Table 3). We used the effective dynamic compliance, instead 
of the static compliance, to calculate this score. This is because 
we do not routinely measure plateau pressures in our ICU. 
Although these compliances are not necessarily identical. we 
have no reason to believe that they would be significantly 
different in the particular case of our patients. Except for 
patient D.W., who was a 13-year-old boy and had a 6.0 endo-
tracheal tube (which may offer some resistance to flow), all 
other patients had large-diameter endotracheal tubes (8.0 in 
two patients, 9.0 in the remaining two). Furthermore, none had 
a history of airway hyperreactivity or copious secretions, and 
they did not develop clinical bronchospasm during their lCU 
stay. More important than the degree of lung injury at the time 
of transplantation is the dramatic improvement seen after these 
patients received a well-functioning liver allograft, which is in 
sharp contrast to the grim natural history this combination of 
failing organs has had until now. 
We believe it is extremely important to obtain quantitative 
respiratory cultures prior to proceeding with the transplant 
operation. Standard clinical criteria are simply too unreliable 
to distinguish ARDS from an infectious process in this difficult 
setting, and quantitative BAL or PBS should be a part of the 
diagnostic work-up in this population. 
It is important to recognize that the scope of our observations 
is limited to a very specific patient population-that is, those 
with ARDS secondary to liver failure. Extreme care should be 
taken not to extrapolate our findings to other patients, such as 
those with ARDS secondary to sepsis or pancreatitis, who most 
likely account for a larger number of patients awaiting liver 
transplantation. We need to define the conditions under which 
OL TX can be carried out with a reasonable expectation of 
success, but as our experience with this small series of patients 
demonstrates-and given careful selection criteria-ARDS sec-
ondary to liver failure does not necessarily follow an inexorable 
progression to death. 
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